Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Amgen to Buy Horizon Therapeutics
Amgen announced it is acquiring rare disease drug company Horizon Therapeutics, maker of eye disease drugs Tepezza and Uplizna, in a deal valued at $27.8 billion. The company will pay $116.50 in cash per share, a premium of 19.7% to…
Turkey, Lets In The SIFI 6th Biggest Pharma. Company In Europe
The Granting of Marketing Authorizations in Turkey – The Turkish Medicines and Medical Devices Agency (TMMDA) has approved the transfer of marketing authorizations for “SIFI”, a leading ophthalmic company, headquartered in Italy, focusing on eye care since 1935. Leading ophthalmic products, including NETILDEX®, NETIRA® and EYESTIL® will…